Bacteria-derived nanovesicles enhance tumour vaccination by trained immunity
Menée à l'aide de modèles murins, cette étude met en évidence l'intérêt d'une administration intrapéritonéale de vésicules issues de la membrane externe des bactéries à Gram négatif pour augmenter l'efficacité des vaccins antitumoraux
Trained immunity enhances the responsiveness of immune cells to subsequent infections or vaccinations. Here we demonstrate that pre-vaccination with bacteria-derived outer-membrane vesicles, which contain large amounts of pathogen-associated molecular patterns, can be used to potentiate, and enhance, tumour vaccination by trained immunity. Intraperitoneal administration of these outer-membrane vesicles to mice activates inflammasome signalling pathways and induces interleukin-1β secretion. The elevated interleukin-1β increases the generation of antigen-presenting cell progenitors. This results in increased immune response when tumour antigens are delivered, and increases tumour-antigen-specific T-cell activation. This trained immunity increased protection from tumour challenge in two distinct cancer models.